CDC b-roll is produced by the United States Government and is in the public domain. This means that the footage is meant for public use and is not subject to copyright law protections. Permission is not required for use of public domain items. However, we do ask that you cite CDC as the source.
To download any video file, right click on the video link and select “Save target as”.
- White: 32 seconds (1080)media icon
- White alphachannel: 32 seconds (1080)media icon
- White: 32 seconds (4k)media icon
- White alphachannel: 32 seconds (4k)media icon
- White: 1 minute (1080)media icon
- White alphachannel: 1 minute (1080)media icon
- White: 1 minute (4k)media icon
- White alphachannel: 1 minute (4k)media icon
CDC trains U.S. healthcare workers deploying to work in an Ebola Treatment Unit (ETU) in West Africa. Training session topics include appropriate personal protective equipment and environmental safety to prepare clinicians to work safely and efficiently.
A CDC disease detective picks up her assigned gear in preparation for deployment to West Africa to fight the Ebola outbreak, packing a suitcase for deployment, packing maps of West Africa to aid in contact tracing, studying maps of West Africa, receiving protective gear to take to West Africa.
April 21, 2021
This b-roll shows CDC’s newest laboratory training facility, where laboratory scientists prepare for future work with infectious agents. In this facility, scientists can train on required safety measures without the presence of infectious agents. The facility allows scientists to train at all four biosafety levels, and includes two mock high-containment laboratory settings, Biosafety Level 3 (BSL-3) and Level 4 (BSL-4).
In BSL-3 laboratories, scientists work with agents that may cause serious or potentially lethal diseases. Scientists must use BSL-4 laboratories to work with pathogens that cause life-threatening diseases and require the highest level of safety and security, such as those which have no vaccines or treatments. Staff in BSL-4 suit laboratories must wear positive-pressure suits with an air supply and use chemical showers to disinfect the suit before leaving the laboratory. The air flow in a BSL-4 laboratory is unidirectional (outside to inside), ‘single pass’ (not recirculated), and filtered. Rooms are under negative pressure relative to the outside areas so that any leak that develops will draw clean air into the laboratory without letting contaminated air escape.
July 15, 2020
This b-roll depicts the lab work involved in serology testing. This laboratory robot performs all the steps of the SARS-CoV-2 antibody test from sample loading through antibody detection in one workflow, and it can test over 3,600 samples a day. A public health scientist can test about 400 samples a day by hand. The use of automated laboratory robots will improve antibody testing capacity, resulting in more data to help monitor and respond to the COVID-19 pandemic.
PulseNet is a national laboratory network that connects cases of foodborne illnesses cases together using DNA fingerprinting of the bacteria making people sick. Various shots show a microbiologist going through the process of one type of DNA fingerprinting technique, pulsed-field gel electrophoresis (PFGE). The last few clips show database managers analyzing these DNA fingerprints in the national databases in order to detect and define outbreaks.
This video shows examples of recommended practices of what people can do to protect themselves and their families from mosquito bites. Zika and other diseases can be spread through mosquitoes.
In the video are shots of applying insect repellant to children and adults, removing standing water that can be mosquito breeding areas, and properly installing window screens.
Answering a call about an onboard illness on a flight about to arrive into the United States, grabbing a boarding bag and exiting the quarantine station, escorting an actor playing a sick passenger to an interview room, checking her temperature and interviewing her, escorting the actor to the CDC isolation room and continuing the interview, conferring about an illness response and contact investigation inside the quarantine station, footage of the empty isolation room and anteroom, footage of electronic message boards with health messages, loading and unloading the “go bag”.
Answering a call about an onboard illness on a flight about to arrive into the United States, Grabbing a boarding bag and exiting the quarantine station, Conferring about an illness response and contact investigation, Checking an illness response record, entering surveillance data into the computer, and entering the quarantine station.
October 2, 2020
This b-roll depicts people at an employee vaccine clinic getting their seasonal flu vaccine while practicing social distancing and other guidelines to slow the spread of COVID-19. The footage shows people wearing masks, while waiting in line, six feet apart, to check-in for their appointment using a QR code on their smart phone. One person is prepped and then receives their flu vaccine given by a health care provider.
- Socially Distanced Flu Vaccination Clinic: 10 Second Clip 1 | B-Roll Video Description
- Socially Distanced Flu Vaccination Clinic: 10 Second Clip 2 | B-Roll Video Description
- Socially Distanced Flu Vaccination Clinic: 15 Second | B-Roll Video Description
- Socially Distanced Flu Vaccination Clinic: 30 Second | B-Roll Video Description
- Socially Distanced Flu Vaccination Clinic: 56 Second | B-Roll Video Description
As a WHO Collaborating Center, and the U.S. National Influenza Center, CDC routinely receives flu viruses from laboratories in the U.S. and around the world. CDC tests these viruses using a variety of techniques to see how similar they are to the viruses used in the current seasonal influenza vaccine. When changes are detected that may negatively affect how well the current vaccine protects against a virus, CDC will develop a new ‘candidate vaccine virus’ that can be used to make vaccine that protects against the changed flu virus.
The video shows scientists from the Centers for Disease Control and Prevention assembling CDC Trioplex Real-time RT-PCR Assaypdf iconexternal icon kits for shipment to qualified public health labs in the Laboratory Response Network and abroad. The CDC Trioplex Real-time RT-PCR Assay is a diagnostic tool for Zika virus. It is a 3-in-1 test, that allows doctors to tell if an individual is currently infected with chikungunya, dengue, or Zika viruses by using a single sample. This eliminates the need to perform three separate tests to determine which infection a patient might have.
The CDC Trioplex PCR test kit includes four components:
- First vial with the red top contains the dengue primer and probe mix
- Second vial with blue top contains chikungunya primer and probe mix
- Third vial with white top: Zika primer and probe mix
- Fourth vial with green top: RNase P primer and probe mix to verify the presence of nucleic acid in the extracted specimen
- The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Trioplex test on March 17, 2016. The test will not be available in U.S. hospitals or other primary care settings.
CDC and the CDC Foundation are partnering to create Zika prevention kits (ZPKs). The purpose of a ZPK is to provide information and tools to support pregnant women and help them reduce their risk of Zika infection; the ZPK provides pregnant women with an initial supply of prevention tools including repellent, and products that kill mosquito larvae.